chr21-46428552-C-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 2P and 16B. PP3_ModerateBP6_Very_StrongBS1BS2

The NM_006031.6(PCNT):​c.7652C>T​(p.Ala2551Val) variant causes a missense change. The variant allele was found at a frequency of 0.0189 in 1,606,570 control chromosomes in the GnomAD database, including 366 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A2551A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.015 ( 27 hom., cov: 34)
Exomes 𝑓: 0.019 ( 339 hom. )

Consequence

PCNT
NM_006031.6 missense

Scores

5
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 4.87

Publications

8 publications found
Variant links:
Genes affected
PCNT (HGNC:16068): (pericentrin) The protein encoded by this gene binds to calmodulin and is expressed in the centrosome. It is an integral component of the pericentriolar material (PCM). The protein contains a series of coiled-coil domains and a highly conserved PCM targeting motif called the PACT domain near its C-terminus. The protein interacts with the microtubule nucleation component gamma-tubulin and is likely important to normal functioning of the centrosomes, cytoskeleton, and cell-cycle progression. Mutations in this gene cause Seckel syndrome-4 and microcephalic osteodysplastic primordial dwarfism type II. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
PCNT Gene-Disease associations (from GenCC):
  • microcephalic osteodysplastic primordial dwarfism type II
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Moyamoya disease
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
BP6
Variant 21-46428552-C-T is Benign according to our data. Variant chr21-46428552-C-T is described in ClinVar as Benign. ClinVar VariationId is 138605.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0148 (2261/152382) while in subpopulation NFE AF = 0.0236 (1608/68036). AF 95% confidence interval is 0.0227. There are 27 homozygotes in GnomAd4. There are 1096 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 27 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PCNTNM_006031.6 linkc.7652C>T p.Ala2551Val missense_variant Exon 35 of 47 ENST00000359568.10 NP_006022.3 O95613-1
PCNTNM_001315529.2 linkc.7298C>T p.Ala2433Val missense_variant Exon 35 of 47 NP_001302458.1 O95613-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PCNTENST00000359568.10 linkc.7652C>T p.Ala2551Val missense_variant Exon 35 of 47 1 NM_006031.6 ENSP00000352572.5 O95613-1

Frequencies

GnomAD3 genomes
AF:
0.0148
AC:
2260
AN:
152264
Hom.:
27
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00379
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0138
Gnomad ASJ
AF:
0.00461
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.00207
Gnomad FIN
AF:
0.0203
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0236
Gnomad OTH
AF:
0.0172
GnomAD2 exomes
AF:
0.0140
AC:
3302
AN:
235048
AF XY:
0.0143
show subpopulations
Gnomad AFR exome
AF:
0.00362
Gnomad AMR exome
AF:
0.00739
Gnomad ASJ exome
AF:
0.00608
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0217
Gnomad NFE exome
AF:
0.0229
Gnomad OTH exome
AF:
0.0166
GnomAD4 exome
AF:
0.0193
AC:
28095
AN:
1454188
Hom.:
339
Cov.:
33
AF XY:
0.0190
AC XY:
13768
AN XY:
723538
show subpopulations
African (AFR)
AF:
0.00299
AC:
100
AN:
33422
American (AMR)
AF:
0.00794
AC:
353
AN:
44484
Ashkenazi Jewish (ASJ)
AF:
0.00663
AC:
173
AN:
26076
East Asian (EAS)
AF:
0.0000505
AC:
2
AN:
39636
South Asian (SAS)
AF:
0.00178
AC:
153
AN:
85996
European-Finnish (FIN)
AF:
0.0218
AC:
1053
AN:
48292
Middle Eastern (MID)
AF:
0.0134
AC:
67
AN:
5000
European-Non Finnish (NFE)
AF:
0.0226
AC:
25159
AN:
1111226
Other (OTH)
AF:
0.0172
AC:
1035
AN:
60056
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
1571
3143
4714
6286
7857
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
880
1760
2640
3520
4400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0148
AC:
2261
AN:
152382
Hom.:
27
Cov.:
34
AF XY:
0.0147
AC XY:
1096
AN XY:
74522
show subpopulations
African (AFR)
AF:
0.00377
AC:
157
AN:
41596
American (AMR)
AF:
0.0138
AC:
211
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00461
AC:
16
AN:
3470
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5188
South Asian (SAS)
AF:
0.00207
AC:
10
AN:
4834
European-Finnish (FIN)
AF:
0.0203
AC:
216
AN:
10630
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0236
AC:
1608
AN:
68036
Other (OTH)
AF:
0.0170
AC:
36
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
122
243
365
486
608
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0215
Hom.:
31
Bravo
AF:
0.0138
TwinsUK
AF:
0.0189
AC:
70
ALSPAC
AF:
0.0197
AC:
76
ESP6500AA
AF:
0.00365
AC:
16
ESP6500EA
AF:
0.0162
AC:
139
ExAC
AF:
0.0140
AC:
1684
Asia WGS
AF:
0.00231
AC:
8
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PCNT: PP3, BS1, BS2 -

not specified Benign:3
Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 09, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 31, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Microcephalic osteodysplastic primordial dwarfism type II Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 06, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.52
CADD
Pathogenic
33
DANN
Uncertain
1.0
DEOGEN2
Benign
0.045
T
Eigen
Benign
0.18
Eigen_PC
Benign
0.17
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Benign
0.78
T
MetaRNN
Benign
0.0044
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.6
M
PhyloP100
4.9
PrimateAI
Benign
0.38
T
PROVEAN
Uncertain
-2.6
D
REVEL
Benign
0.11
Sift
Benign
0.043
D
Sift4G
Uncertain
0.049
D
Polyphen
0.26
B
Vest4
0.13
MPC
0.091
ClinPred
0.027
T
GERP RS
3.5
Varity_R
0.090
gMVP
0.023
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.94
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.94
Position offset: -2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12481791; hg19: chr21-47848466; API